# FDA recall D-0848-2022

> **McKesson Corporation dba McKesson Drug Company** · Class II · drug recall initiated 2022-04-21.

## Product

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL bottle, Rx only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310 Distributed by: McKesson Corporation dba Sky Packaging 4071 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-977-64

## Reason for recall

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

## Distribution

Nationwide in the United States including Guam and the Northern Mariana Islands.

## Key facts

- **Recall number:** D-0848-2022
- **Recalling firm:** McKesson Corporation dba McKesson Drug Company
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2022-04-21
- **Report date:** 2022-05-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Memphis, TN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0848-2022

## Citation

> AI Analytics. FDA recall D-0848-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0848-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*